| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026220014 |
| P356 | DOI | 10.1038/NPP.2013.71 |
| P932 | PMC publication ID | 3717543 |
| P698 | PubMed publication ID | 23511700 |
| P5875 | ResearchGate publication ID | 236063945 |
| P50 | author | Robert Dantzer | Q3434896 |
| Keith W. Kelley | Q47809179 | ||
| P2093 | author name string | Adam K Walker | |
| Robin A Smith | |||
| David P Budac | |||
| Anna W Lee | |||
| Brent Beenders | |||
| Stephanie Bisulco | |||
| P2860 | cites work | Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors | Q48099473 |
| Stress- and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity | Q48635018 | ||
| Acute inflammation and negative mood: mediation by cytokine activation | Q48863588 | ||
| Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats | Q48880251 | ||
| AMPA-receptors are involved in the expression of amphetamine-induced behavioural sensitisation, but not in the expression of amphetamine-induced conditioned activity in mice. | Q52181935 | ||
| Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway | Q85047994 | ||
| From inflammation to sickness and depression: when the immune system subjugates the brain | Q24633527 | ||
| The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine | Q28276943 | ||
| Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse | Q28317802 | ||
| Human microglia convert l-tryptophan into the neurotoxin quinolinic acid | Q28379366 | ||
| Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior | Q28508390 | ||
| NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses | Q30471587 | ||
| Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress | Q33708133 | ||
| Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin | Q33715452 | ||
| Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? | Q33970888 | ||
| Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior. | Q34012783 | ||
| Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. | Q34655648 | ||
| The HPA axis in major depression: classical theories and new developments | Q34803590 | ||
| Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide | Q35690505 | ||
| Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. | Q35995176 | ||
| The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects | Q37067679 | ||
| Regulatory role of anesthetics on heme oxygenase-1. | Q37779567 | ||
| Dual roles for perivascular macrophages in immune-to-brain signaling | Q40665015 | ||
| Cytokine-associated emotional and cognitive disturbances in humans | Q43601371 | ||
| Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection | Q43718624 | ||
| Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. | Q43942974 | ||
| Increase in concentration of waking salivary cortisol in recovered patients with depression | Q44599668 | ||
| Conditioned taste aversion with lipopolysaccharide and peptidoglycan does not activate cytokine gene expression in the spleen and hypothalamus of mice. | Q44753772 | ||
| Prolonged exposure to ketamine increases brain derived neurotrophic factor levels in developing rat brains | Q46159780 | ||
| Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma? | Q46515190 | ||
| Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus | Q46989886 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipopolysaccharide | Q421804 |
| P304 | page(s) | 1609-1616 | |
| P577 | publication date | 2013-03-19 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice | |
| P478 | volume | 38 |
| Q92043421 | (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism |
| Q47741629 | A single dose of S-ketamine induces long-term antidepressant effects and decreases oxidative stress in adulthood rats following maternal deprivation. |
| Q33553907 | Activation of lung toll-like receptors does not exacerbate sickness responses to lipopolysaccharide in mice |
| Q33635571 | Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome |
| Q54966162 | Amelioration of Pentylenetetrazole-Induced Seizures by Modulators of Sigma, N-Methyl-D-Aspartate, and Ryanodine Receptors in Mice. |
| Q37254521 | An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation |
| Q90477448 | Animal models of major depression: drawbacks and challenges |
| Q33635653 | Animal models to improve our understanding and treatment of suicidal behavior |
| Q21129276 | Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants |
| Q92660354 | Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression |
| Q35902490 | Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE). |
| Q33704099 | Biomarkers for depression: recent insights, current challenges and future prospects |
| Q37310546 | Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets |
| Q47446670 | Central histaminergic system interplay with suppressive effects of immune challenge on food intake in chicken. |
| Q47618120 | Chronic N-acetylcysteine treatment alleviates acute lipopolysaccharide-induced working memory deficit through upregulating caveolin-1 and synaptophysin in mice |
| Q43083700 | Conceptual confluence: the kynurenine pathway as a common target for ketamine and the convergence of the inflammation and glutamate hypotheses of depression |
| Q28830670 | Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression |
| Q52667723 | Convergent Mechanisms Underlying Rapid Antidepressant Action. |
| Q26772830 | Depression as a Glial-Based Synaptic Dysfunction |
| Q57183995 | Disruption of the NMDA receptor GluN2A subunit abolishes inflammation-induced depression |
| Q47799470 | Effects of Jiaotaiwan on depressive-like behavior in mice after lipopolysaccharide administration |
| Q42740692 | Endoplasmic Reticulum Stress and Disrupted Neurogenesis in the Brain Are Associated with Cognitive Impairment and Depressive-Like Behavior after Spinal Cord Injury. |
| Q36584878 | Exercise, inflammation, and fatigue in cancer survivors |
| Q96298614 | Extrasynaptic CaMKIIα is involved in the antidepressant effects of ketamine by downregulating GluN2B receptors in an LPS-induced depression model |
| Q90410809 | FGF21 Attenuated LPS-Induced Depressive-Like Behavior via Inhibiting the Inflammatory Pathway |
| Q47999379 | Fish oil supplementation attenuates neuroinflammation and alleviates depressive-like behavior in rats submitted to repeated lipopolysaccharide |
| Q52564304 | Genetic deletion of xCT attenuates peripheral and central inflammation and mitigates LPS-induced sickness and depressive-like behavior in mice. |
| Q89286789 | Gentiopicroside abrogates lipopolysaccharide-induced depressive-like behavior in mice through tryptophan-degrading pathway |
| Q47897568 | Glial cell responses in a murine multifactorial perinatal brain injury model. |
| Q48049846 | Hesperidin Alleviates Lipopolysaccharide-Induced Neuroinflammation in Mice by Promoting the miRNA-132 Pathway |
| Q33620624 | IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy |
| Q47694934 | Immune-based strategies for mood disorders: facts and challenges |
| Q61453866 | Indoleamine 2,3-Dioxygenase-Dependent Neurotoxic Kynurenine Metabolism Contributes to Poststroke Depression Induced in Mice by Ischemic Stroke along with Spatial Restraint Stress |
| Q36244916 | Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory |
| Q89963817 | Indoleamine-2,3-Dioxygenase Mediates Emotional Deficits by the Kynurenine/Tryptophan Pathway in the Ethanol Addiction/Withdrawal Mouse Model |
| Q31141746 | Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications |
| Q26749497 | Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery |
| Q26781620 | Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment |
| Q38954648 | Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders |
| Q38366476 | Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue |
| Q37089253 | Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications |
| Q93185054 | Inhibition of Indoleamine 2,3 Dioxygenase Does Not Improve Cancer-Related Symptoms in a Murine Model of Human Papilloma Virus-Related Head and Neck Cancer |
| Q48362770 | Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour |
| Q91652721 | Interactions between pyridostigmine bromide and stress on glutamatergic neurochemistry: Insights from a rat model of Gulf War Illness |
| Q40352700 | Involvement of Host Defense Mechanisms against Toxoplasma gondii Infection in Anhedonic and Despair-Like Behaviors in Mice |
| Q34051382 | Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? |
| Q55438088 | Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. |
| Q38254452 | Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders? |
| Q37330681 | Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties |
| Q47722395 | Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression |
| Q26782867 | Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology |
| Q36945317 | Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge |
| Q37114639 | Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies |
| Q88591012 | Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation |
| Q26773067 | Kynurenine pathway metabolites and suicidality |
| Q21129356 | Kynurenines in CNS disease: regulation by inflammatory cytokines |
| Q48571192 | LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain |
| Q89486095 | Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice |
| Q34357034 | Lipopolysaccharide reduces incentive motivation while boosting preference for high reward in mice |
| Q30630772 | Lipopolysaccharide-induced depressive-like behavior is associated with α₁-adrenoceptor dependent downregulation of the membrane GluR1 subunit in the mouse medial prefrontal cortex and ventral tegmental area |
| Q60304624 | Low dose aspirin blocks breast cancer-induced cognitive impairment in mice |
| Q36749816 | Low-Level Stress Induces Production of Neuroprotective Factors in Wild-Type but Not BDNF+/- Mice: Interleukin-10 and Kynurenic Acid |
| Q40500968 | Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis. |
| Q30251615 | Mastocytosis in adulthood and neuropsychiatric disorders |
| Q91868190 | Maternal immune activation in rats blunts brain cytokine and kynurenine pathway responses to a second immune challenge in early adulthood |
| Q52658612 | Mechanisms of ketamine action as an antidepressant. |
| Q48088648 | Microglia-dependent alteration of glutamatergic synaptic transmission and plasticity in the hippocampus during peripheral inflammation. |
| Q41699494 | Microglia: An Interface between the Loss of Neuroplasticity and Depression |
| Q89859733 | Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin |
| Q60991606 | Motivational changes that develop in a mouse model of inflammation-induced depression are independent of indoleamine 2,3 dioxygenase |
| Q47744128 | NLRP3 Inflammasome Contributes to Lipopolysaccharide-induced Depressive-Like Behaviors via Indoleamine 2,3-dioxygenase Induction. |
| Q35586357 | NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism |
| Q35132317 | Neuroanatomical and functional characterization of CRF neurons of the amygdala using a novel transgenic mouse model. |
| Q47851508 | Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa |
| Q37432089 | Neuroinflammation and comorbidity of pain and depression |
| Q37648274 | Neuropathology of mood disorders: do we see the stigmata of inflammation? |
| Q26829880 | Neuropsychiatric comorbidity in obesity: role of inflammatory processes |
| Q30839124 | Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation |
| Q35554122 | Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice. |
| Q92535017 | Perturbation of Ephrin Receptor Signaling and Glutamatergic Transmission in the Hypothalamus in Depression Using Proteomics Integrated With Metabolomics |
| Q48061279 | Piperine Augments the Protective Effect of Curcumin Against Lipopolysaccharide-Induced Neurobehavioral and Neurochemical Deficits in Mice |
| Q100504020 | Post-inflammatory behavioural despair in male mice is associated with reduced cortical glutamate-glutamine ratios, and circulating lipid and energy metabolites |
| Q26782274 | Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants |
| Q35647362 | Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder |
| Q47415330 | Quantitative Analysis of Kynurenine Aminotransferase II in the Adult Rat Brain Reveals High Expression in Proliferative Zones and Corpus Callosum |
| Q33918411 | Quinolinate Phosphoribosyltransferase is an Antiviral Host Factor Against Hepatitis C Virus Infection |
| Q92873306 | Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective |
| Q36665332 | Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder |
| Q39777451 | Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice. |
| Q30449121 | Repetitive concussive traumatic brain injury interacts with post-injury foot shock stress to worsen social and depression-like behavior in mice |
| Q35580361 | Rodent models of treatment-resistant depression. |
| Q38893391 | Role of Adiposity-Driven Inflammation in Depressive Morbidity |
| Q38885617 | Role of Inflammation in Suicide: From Mechanisms to Treatment |
| Q38843536 | Role of Inflammation in the Development of Neuropsychiatric Symptom Domains: Evidence and Mechanisms. |
| Q38843539 | Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders |
| Q60062706 | Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies |
| Q48413880 | Role of brain transmigrating neutrophils in depression-like behavior during systemic infection |
| Q38844375 | Role of the Kynurenine Metabolism Pathway in Inflammation-Induced Depression: Preclinical Approaches |
| Q47107749 | Role of the indoleamine-2,3-dioxygenase/kynurenine pathway of tryptophan metabolism in behavioral alterations in a hepatic encephalopathy rat model |
| Q41173215 | Serum kynurenic acid is reduced in affective psychosis. |
| Q38363925 | Sick and tired: mood, fatigue, and inflammation in cancer. |
| Q98891802 | Sick for science: experimental endotoxemia as a translational tool to develop and test new therapies for inflammation-associated depression |
| Q38676972 | Sleep disturbance and kynurenine metabolism in depression |
| Q38843530 | Suicidality and Activation of the Kynurenine Pathway of Tryptophan Metabolism |
| Q38831208 | Suppression of Th1 differentiation by tryptophan supplementation in vivo |
| Q35633911 | Systemic inflammation in early neonatal mice induces transient and lasting neurodegenerative effects |
| Q94464760 | Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges |
| Q47639681 | The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice |
| Q38253558 | The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia. |
| Q59795549 | The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder |
| Q57820177 | The Neuroinflammation Perspective of Depression: Reuniting the Outstanding Mechanisms of the Pathophysiology |
| Q91303004 | The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response |
| Q93066099 | The kynurenine pathway: a finger in every pie |
| Q37470201 | The neuroimmune basis of fatigue |
| Q36754254 | The rapid antidepressant effect of ketamine in rats is associated with down-regulation of pro-inflammatory cytokines in the hippocampus |
| Q38681725 | The role of inflammation in depression: from evolutionary imperative to modern treatment target |
| Q38828405 | Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation |
| Q59136835 | Time and frequency dependent changes in resting state EEG functional connectivity following lipopolysaccharide challenge in rats |
| Q54118164 | Total Saikosaponins of Bupleurum yinchowense reduces depressive, anxiety-like behavior and increases synaptic proteins expression in chronic corticosterine-treated mice. |
| Q42495952 | Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice |
| Q47826628 | Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain. |
| Q47137050 | Visceral Inflammation and Immune Activation Stress the Brain |
| Q37603029 | Voluntary wheel running does not affect lipopolysaccharide-induced depressive-like behavior in young adult and aged mice |
Search more.